Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
This clinical trial update describes the CCANED-CIPHER study, an ongoing investigation using AI-based transcriptomic profiling of platelets …
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma [Phase 4]
Phase 4 real-world trial update evaluating enhanced recovery after surgery–based multimodal preemptive analgesia for perioperative managemen…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer
A clinical trial update describes a CFD-based dosimetry and pre-treatment planning platform to support personalized transarterial therapies …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
A study is evaluating C-CAR031 for Glypican-3 positive advanced/recurrent hepatocellular carcinoma. It spans Phase 1 and Phase 2 and is curr…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study [Phase 2]
A Phase 2 study evaluating Sorafenib in patients with previously treated advanced hepatocellular carcinoma assessed its efficacy and safety …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma [Phase 2, Phase 3]
An update on a Phase 2/Phase 3 trial comparing Pracytarabine to Regorafenib for hepatocellular carcinoma, focusing on efficacy and safety, w…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) [Phase 3]
A Phase 3 study evaluating atezolizumab plus bevacizumab, with or without tiragolumab, in patients with untreated locally advanced or metast…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Target-specific immunoPET Imaging of Digestive System Carcinoma [NA]
A recruiting clinical trial evaluating a target-specific immunoPET imaging agent for digestive system carcinomas across multiple digestive c…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer [Phase 2]
Phase 2 clinical trial update evaluating stereotactic body proton radiotherapy for hepatocellular carcinoma; the study has been terminated. …
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma [NA]
A planned clinical study to evaluate whether acute endurance exercise affects the production of FGF21 and follistatin in patients with hepat…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC [Phase 2]
Phase 2 trial evaluating HAIC sequential transarterial embolization with lenvatinib and tislelizumab for unresectable hepatocellular carcino…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation
A retrospective study assessing safety and efficacy of combining locoregional therapies with anti-VEGF/TKIs and immune checkpoint inhibitors…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma [Phase 2]
Phase IIb study of AST-3424 in AKR1C3-high expressing advanced hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation [Phase 3]
Phase 3 trial evaluating camrelizumab plus apatinib (rivoceranib) as adjuvant therapy for hepatocellular carcinoma at high risk of recurrenc…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma [Phase 2, Phase 3]
This clinical trial update describes a Phase II/III randomized study comparing TACE plus an oral triple-agent cocktail versus TACE plus firs…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update evaluating first-line durvalumab and tremelimumab in combination with lenvatinib for unresectable hepatocellular carcin…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma
Clinical trial update describing a survey of cabozantinib tablets used to treat hepatocellular carcinoma, sponsored by Takeda, with the stud…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer [NA]
A clinical trial investigating preoperative Lactobacillus reuteri with neoadjuvant immunotherapy for primary resectable hepatocellular carci…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating LVGN3616 and LVGN6051±LVGN7409 with nab-paclitaxel or bevacizumab and cyclophosphamide in various metastatic solid …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
An observational basket trial sponsored by Elephas aims to collect tissue to develop and train a live tumor diagnostic platform across multi…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
This clinical trial update indicates a study on using liquid biopsy to characterize hepatocellular carcinoma after Yttrium-90 therapy and is…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion [Phase 2]
Phase 2 clinical trial evaluating immunotherapy alone versus immunotherapy plus radiotherapy in patients with hepatocellular carcinoma with …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study [NA]
A pilot study investigates downstaging unresectable hepatocellular carcinoma to resectable disease using a combination of immunotherapy and …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Study Protocol: LIVER-R
An observational study protocol called LIVER-R sponsored by AstraZeneca focusing on hepatobiliary cancers, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer [Phase 1, Phase 2]
An update on Phase 1/2 trials evaluating nivolumab, alone or in combination with other agents, for advanced hepatocellular carcinoma, with t…